Related Experiment Video
Updated: Jun 24, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Critically ill infants benefit from early administration of protein and energy-enriched formula: a randomized
Dick A van Waardenburg1, Carlijn T de Betue, Johannes B van Goudoever
1Department of Pediatrics, Maastricht University and Medical Center, P Debeyelaan 25, Maastricht, The Netherlands. d.vanwaardenburg@mumc.n
Insights
A protein and energy-enriched infant formula improved nutrient intake and nitrogen balance in critically ill infants with respiratory failure. This enhanced nutritional support was well-tolerated and beneficial for recovery.
Area of Science:
- Pediatric critical care nutrition
- Infant respiratory failure management
- Metabolic balance studies in infants
Background:
- Nutritional support is crucial for critically ill infants but often hindered by feeding challenges.
- Protein and energy-enriched formulas may overcome these barriers, promoting anabolism.
- Respiratory syncytial virus (RSV)-bronchiolitis is a common cause of respiratory failure in infants.
Purpose of the Study:
- To evaluate the efficacy of a protein and energy-enriched formula compared to a standard formula in critically ill infants.
- To assess nutrient delivery, energy and nitrogen balance, and plasma amino acid concentrations.
- To determine the tolerance and safety of the enriched formula.
Main Methods:
- Randomized controlled trial involving infants with respiratory failure due to RSV-bronchiolitis.
- Comparison of a protein and energy-enriched formula (PE-formula) versus a standard formula (S-formula).
- Study duration of 5 days post-admission, monitoring nutrient intake, balance, and amino acid levels.
Main Results:
- Infants receiving the PE-formula achieved higher nutrient intakes, meeting population reference intake (PRI) earlier than those on S-formula.
- Significantly greater cumulative nitrogen balance (cNB) and energy balance (cEB) were observed in the PE-formula group (P<0.01).
- Essential amino acid levels were higher in PE-fed infants, remaining within reference limits, unlike in S-fed infants.
Conclusions:
- Early use of protein and energy-enriched formula in critically ill infants is well-tolerated.
- Enriched formula promotes adequate nutrient intake and improves energy and nitrogen balance.
- No adverse effects were observed, suggesting a safe and effective nutritional strategy.
Background & Aims:
Nutritional support improves outcome in critically ill infants but is impeded by fluid restriction, gastric intolerance and feeding interruptions. Protein and energy-enriched infant formulas may help to achieve nutritional targets earlier during admission and promote anabolism.
Methods:
Randomized controlled design. Infants with respiratory failure due to RSV-bronchiolitis received a protein and energy-enriched formula (PE-formula, n=8) or a standard formula (S-formula, n=10) during 5 days after admission.
Primary Outcome:
nutrient delivery, energy and nitrogen balance and plasma amino acid concentrations. Secondary outcome: tolerance and safety.
Results:
Nutrient intakes were higher in PE fed infants and met population reference intake (PRI) on day 3-5 whilst in S-fed infants PRI was met on day 5 only. Cumulative nitrogen balance (cNB) and energy balance (cEB) were higher in PE-infants compared to S-infants (cNB: 866+/-113 vs. 296+/-71 mg/kg; cEB: 151+/-31 and 26+/-17 kcal/kg, both P<0.01). Essential amino acid levels were higher in PE-infants but within reference limits whereas below these limits in S-infants. Both formulas were well tolerated.
Conclusions:
Early administration of a protein and energy-enriched formula in critically ill infants is well tolerated, promotes a more adequate nutrient intake and improves energy and nitrogen balance without adverse effects.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drug Dosing: Infants and Children
Chronic Kidney Disease III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution